← Open Payments lookup

NILGUN GIRAY BELLEZZA: Open Payments

NPI 1588740047 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,699 in 76 payments from 15 companies in 2025. Trend: 2023 $1,256 · 2024 $1,067 · 2025 $1,699

Food & beverage: $1,587Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$367
Teva Pharmaceuticals USA, Inc.4$146
E.R. Squibb & Sons, L.L.C.6$146
Neurocrine BioSciences, Inc.2$141
ABBVIE INC.10$136
Axsome Therapeutics, Inc.1$123
Otsuka America Pharmaceutical, Inc.6$115
Janssen Pharmaceuticals, Inc5$107
Corium, LLC7$93
Lundbeck LLC3$81

Products named: CAPLYTA, REXULTI, COBENFY, INGREZZA, VRAYLAR, Auvelity, Azstarys, TRINTELLIX.

Industry payments across TX — which companies pay providers there.